Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Monge

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The Journal of Rheumatology|July 15, 2022
Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the LiteratureLina Jeantin, Tiphaine Lenfant, Pierre Bataille, et al.
Scientific Reports|October 20, 2018
Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell nicheMarina A Aleksinskaya, Matthieu Monge, Michiel Siebelt, et al.
Lancet (London, England)|January 30, 2015
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trialMichel Azizi, Marc Sapoval, Philippe Gosse, et al.
Cardiovascular Research|August 23, 2011
MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemiaCoen van Solingen, Hetty C de Boer, Roel Bijkerk, et al.
Journal of Cellular and Molecular Medicine|January 6, 2009
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesisCoen van Solingen, Leonard Seghers, Roel Bijkerk, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension)Philippe Gosse, Antoine Cremer, Helena Pereira, et al.
Journal of the American Heart Association|October 12, 2017
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) TrialPierre-Yves Courand, Helena Pereira, Costantino Del Giudice, et al.
Circulation|September 1, 2016
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialMichel Azizi, Helena Pereira, Idir Hamdidouche, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 7, 2026
Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohortElias Karam, Charles de Ponthaud, Alexandra Nassar, et al.
Annals of Surgery|June 4, 2026
Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National CohortClément Pastier, Marc-Anthony Chouillard, Charles De Ponthaud, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The Journal of Rheumatology|July 15, 2022
Antineutrophil Cytoplasm Antibody-Associated Vasculitides Valvular Impairment: Multicenter Retrospective Study and Systematic Review of the LiteratureLina Jeantin, Tiphaine Lenfant, Pierre Bataille, et al.
Scientific Reports|October 20, 2018
Chronic kidney failure mineral bone disorder leads to a permanent loss of hematopoietic stem cells through dysfunction of the stem cell nicheMarina A Aleksinskaya, Matthieu Monge, Michiel Siebelt, et al.
Lancet (London, England)|January 30, 2015
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trialMichel Azizi, Marc Sapoval, Philippe Gosse, et al.
Cardiovascular Research|August 23, 2011
MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1(+)/Lin(-) progenitor cells in ischaemiaCoen van Solingen, Hetty C de Boer, Roel Bijkerk, et al.
Journal of Cellular and Molecular Medicine|January 6, 2009
Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesisCoen van Solingen, Leonard Seghers, Roel Bijkerk, et al.
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension)Philippe Gosse, Antoine Cremer, Helena Pereira, et al.
Journal of the American Heart Association|October 12, 2017
Abdominal Aortic Calcifications Influences the Systemic and Renal Hemodynamic Response to Renal Denervation in the DENERHTN (Renal Denervation for Hypertension) TrialPierre-Yves Courand, Helena Pereira, Costantino Del Giudice, et al.
Circulation|September 1, 2016
Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) TrialMichel Azizi, Helena Pereira, Idir Hamdidouche, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 7, 2026
Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohortElias Karam, Charles de Ponthaud, Alexandra Nassar, et al.
Annals of Surgery|June 4, 2026
Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National CohortClément Pastier, Marc-Anthony Chouillard, Charles De Ponthaud, et al.
Pageof 4